Canine cardiology covers a surprisingly wide landscape of conditions, from inherited defects that appear in puppyhood to degenerative valve disease that creeps in during middle age. Heart disease is among the leading causes of death in pet dogs, yet the specifics vary enormously by breed, body size, and lifestyle. Some breeds carry genetic mutations that make cardiac screening a near-certainty at some point in their lives, while others develop problems tied to diet, parasites, or sheer anatomical bad luck. Understanding how a dog’s heart works, what can go wrong, and what modern veterinary medicine can do about it gives owners a meaningful head start.
How the Canine Heart Compares to Ours
Dogs share the same basic four-chambered heart design as humans, but the performance ceiling in athletic breeds is staggering. Alaskan Huskies competing in long-distance sled races can reach oxygen-uptake levels roughly four times what a trained human marathon runner achieves. One study measured their VOâ‚‚max at about 199 mL/kg/min, compared to around 54 mL/kg/min in competitive human runners.1Equine and Comparative Exercise Physiology. Effects of endurance training on VO2max and submaximal blood lactate concentrations of untrained sled dogs That kind of aerobic output does not come from a bigger heart alone. The mitochondria inside their skeletal muscle are remarkably efficient at converting oxygen into energy.
Research on muscle tissue from Alaskan Huskies found that their mitochondrial respiratory rates were the highest ever recorded in mammalian skeletal muscle, far exceeding values seen even in competitive racing horses. Human muscle typically operates at roughly a quarter to two-thirds of the levels these dogs produce.2PLOS ONE. Mitochondrial respiration in highly aerobic canines in the non-raced state and after a 1600-km sled dog race Researchers noted that perhaps the only other mammal in the same aerobic league is the pronghorn antelope. This extreme cardiovascular fitness in certain breeds is relevant beyond sled racing: it reflects the enormous range of cardiac demand across the species. A Chihuahua’s heart faces very different mechanical stresses than a Greyhound’s, and that variation helps explain why heart disease looks so different from one breed to another.
Myxomatous Mitral Valve Disease
The single most common acquired heart condition in dogs is myxomatous mitral valve disease, often shortened to MMVD. It accounts for the majority of canine heart failure cases and is especially prevalent in small and medium breeds, including Cavalier King Charles Spaniels, Dachshunds, and Miniature Poodles. The disease involves a gradual breakdown of the mitral valve’s internal structure. Connective-tissue components swell with water-absorbing molecules, the collagen layer weakens, and the valve leaflets thicken and distort.3PubMed. Pathology of myxomatous mitral valve disease in the dog Over time the valve stops closing properly, allowing blood to leak backward with every heartbeat.
This backflow, called mitral regurgitation, is what drives the disease forward. Early on, many dogs show no symptoms at all; a vet might hear a heart murmur during a routine exam and nothing more. As regurgitation worsens over months or years, the left atrium and left ventricle enlarge to compensate for the extra blood volume. Eventually this remodeling can trigger complications like torn chordae (the tiny cords anchoring the valve), atrial tears, and congestive heart failure.4PubMed. Pathology of myxomatous mitral valve disease in the dog In a study of over 250 dogs with the condition, about 61 percent had both mitral valve leaflets affected, while roughly a third had only the front leaflet involved.5Journal of Veterinary Internal Medicine. Survival Characteristics and Prognostic Variables of Dogs with Preclinical Chronic Degenerative Mitral Valve Disease Attributable to Myxomatous Degeneration
The tricky part for owners is the long silent phase. A dog can have a detectable murmur for years before showing any outward signs of trouble. This is why regular veterinary check-ups with auscultation matter so much in predisposed breeds. Once the disease is identified, tracking its progression with periodic imaging lets you and your vet decide when intervention should begin.
Dilated Cardiomyopathy and Its Genetic Roots
Dilated cardiomyopathy, or DCM, is the big-breed counterpart to MMVD. Instead of a leaky valve, the heart muscle itself weakens and stretches, losing its ability to pump effectively. Large and giant breeds bear the highest risk: Doberman Pinschers, Great Danes, Irish Wolfhounds, and Boxers appear disproportionately in clinical populations. In Dobermans specifically, DCM follows an autosomal dominant inheritance pattern, meaning a single copy of the defective gene from either parent can be enough to cause disease.6Journal of Veterinary Internal Medicine. A Prospective Genetic Evaluation of Familial Dilated Cardiomyopathy in the Doberman Pinscher
Two specific genetic variants have been identified so far in Dobermans. One involves the PDK4 gene. A second, discovered through whole-genome sequencing of an affected Doberman family that lacked the PDK4 variant, sits in the titin gene, a massive protein that acts like a molecular spring inside heart muscle cells.7PubMed. A missense variant in the titin gene in Doberman pinscher dogs with familial dilated cardiomyopathy and sudden cardiac death Titin mutations are also a known cause of human DCM, which makes the Doberman a valuable natural model for studying the disease across species. Genetic testing for both variants is commercially available, and many responsible Doberman breeders now screen their dogs before making breeding decisions.
Boxers face a related but distinct condition called arrhythmogenic right ventricular cardiomyopathy, or ARVC. Rather than the entire heart dilating, the right ventricle’s muscle is progressively replaced by fatty or fibrous tissue. This replacement disrupts the heart’s electrical signaling and can cause dangerous arrhythmias, fainting episodes, or sudden death.8PubMed. Arrhythmogenic right ventricular cardiomyopathy in dogs Histopathological studies of Boxer hearts with ARVC found that fatty replacement occupied roughly 40 percent of the right ventricular wall area, compared to about 14 percent in healthy controls.9Circulation. Arrhythmogenic Right Ventricular Cardiomyopathy Causing Sudden Cardiac Death in Boxer Dogs The condition shares so many features with its human counterpart that researchers have proposed the Boxer as a natural animal model for human arrhythmogenic cardiomyopathy.10PubMed Central. Arrhythmogenic right ventricular cardiomyopathy in Boxer dogs: the diagnosis as a link to the human disease
Congenital Heart Defects
Some dogs are born with structural heart problems. Early epidemiologic work found that the overall prevalence of cardiovascular malformations in dogs presented to a large veterinary teaching hospital was about 7 per 1,000, with purebred dogs significantly more affected than mixed breeds. The specific defects were not evenly distributed across breeds, either: patent ductus arteriosus, pulmonic stenosis, subaortic stenosis, and tetralogy of Fallot each showed strong breed predilections.11Circulation Research. Epidemiologic and Genetic Studies of Congenital Heart Disease in the Dog
Subaortic stenosis, or SAS, is one of the more serious congenital conditions. A ridge of abnormal tissue below the aortic valve narrows the outflow tract, forcing the heart to work harder to pump blood into circulation. Breeds at highest risk include Newfoundlands, Rottweilers, Boxers, and Golden Retrievers. In a large retrospective study, Newfoundlands had an odds ratio of about 88 for the condition compared to the general dog population.12Journal of Veterinary Internal Medicine. The Natural Clinical History of Canine Congenital Subaortic Stenosis Dogs with mild obstruction often live relatively normal lives. Those with severe obstruction face a very different prognosis: median survival in untreated severe cases was under 19 months, and about half of those dogs died suddenly, mostly within the first three years of life.13Journal of Veterinary Internal Medicine. The Natural Clinical History of Canine Congenital Subaortic Stenosis
A more recent long-term study of 166 dogs with SAS confirmed the severity-dependent survival pattern. Dogs with mild disease had a median survival of about 10.6 years, while those in the most severe category survived a median of just 3 years.14PubMed. Natural history of subaortic stenosis in 166 dogs (1999-2011) Patent ductus arteriosus, the most common congenital cardiovascular defect in dogs, is now routinely corrected through minimally invasive catheter-based procedures at veterinary specialty centers, and similar catheter techniques are used for pulmonic stenosis and some septal defects.
Diet, Taurine, and the Grain-Free Controversy
Starting around 2018, reports emerged linking certain grain-free dog foods, especially those heavy in legumes and pulses like peas, lentils, and chickpeas, to cases of DCM in breeds not typically predisposed to it. The U.S. Food and Drug Administration issued alerts, and the veterinary community scrambled to understand the mechanism. One leading hypothesis centered on taurine, an amino acid critical for heart muscle function. Some pulse-based diets appeared to impair taurine status in dogs, and taurine deficiency is a known trigger for DCM.
A controlled feeding trial found measurable cardiac changes in dogs after just 28 days on a wrinkled-pea-based diet. Dogs on that diet showed significantly higher blood levels of NT-proBNP, a biomarker of cardiac stress, and increased left ventricular diameter during contraction compared to dogs on a commercial grain-containing diet. The researchers suggested that specific starch and oligosaccharide components of these ingredients, rather than simply fiber content, might be involved.15PLOS ONE. Effects of a 28-day feeding trial of grain-containing versus pulse-based diets on cardiac function, taurine levels and digestibility in domestic dogs However, a broader review of the evidence concluded that the relationship between pulse ingredients and canine DCM remains undefined. While pulses have been implicated in affecting taurine status, the data are not yet strong enough to prove a causal chain from specific ingredients to heart disease.16Journal of Animal Science. Special topic: The association between pulse ingredients and canine dilated cardiomyopathy: addressing the knowledge gaps before establishing causation
The practical upshot for dog owners is nuanced. Most veterinary cardiologists recommend caution with diets that list legumes or potatoes as a primary ingredient, particularly for breeds already at some DCM risk. If your dog has been eating a pulse-heavy diet and you are concerned, talking to your vet about a dietary switch and potentially checking taurine levels is reasonable. The science has not fully settled, but the early signals were concerning enough to warrant attention.
Heartworm and Infectious Cardiac Disease
Dirofilaria immitis, the heartworm parasite, remains one of the most preventable yet devastating cardiac threats to dogs. Transmitted by mosquitoes, the larvae mature into foot-long worms that lodge in the pulmonary arteries and right heart chambers. The resulting damage is both mechanical and inflammatory. Cardiac biomarkers like troponin I and NT-proBNP become elevated in infected dogs, reflecting active heart muscle injury and developing heart failure, especially in chronic infections. An inflammatory cascade involving C-reactive protein also ramps up in proportion to disease severity, and a strong correlation between pulmonary hypertension and C-reactive protein levels has been documented.17PubMed Central. Cardiopulmonary and inflammatory biomarkers in heartworm disease
Treatment involves killing the adult worms with arsenic-based drugs, a process that carries its own risks because dying worms can block blood vessels in the lungs. Some cardiac biomarker levels improve modestly after successful treatment, but by the time a dog has chronic heartworm disease, lasting cardiac and pulmonary damage may already be in place. Year-round preventive medication is dramatically cheaper and safer than treating an established infection, which is why virtually every veterinary professional considers heartworm prevention non-negotiable regardless of where you live.
Screening and Blood Biomarkers
Two blood tests have become central to canine cardiac screening. NT-proBNP measures stretch on the heart wall; it rises when chambers are enlarged or under volume overload. High-sensitivity cardiac troponin I, or hscTnI, detects ongoing heart-muscle cell damage. Used alone, each test provides useful information. Used together, they become considerably more powerful. A study of dogs with degenerative mitral valve disease found that combining hscTnI and NT-proBNP measurements identified dogs with shorter survival times more accurately than either test on its own. Dogs categorized as high-risk by both markers had significantly worse outcomes than those in the low or medium categories.18Journal of Veterinary Internal Medicine. The Combined Prognostic Potential of Serum High-Sensitivity Cardiac Troponin I and N-Terminal pro-B-Type Natriuretic Peptide Concentrations in Dogs with Degenerative Mitral Valve Disease
Echocardiography, essentially a cardiac ultrasound, remains the gold standard for assessing heart structure and function. It lets a cardiologist measure chamber sizes, wall thickness, valve motion, and blood-flow patterns in real time. Holter monitors, which record heart rhythm over 24 hours, are particularly important for breeds prone to arrhythmias, like Boxers and Dobermans, because dangerous rhythms can be intermittent and easy to miss during a short clinic visit. Machine-learning tools are also beginning to appear in veterinary cardiology: recent work has applied algorithms to heart-rhythm data to help diagnose sinus-node dysfunction from patterns that are difficult for humans to spot consistently.19Journal of Veterinary Internal Medicine. Use of machine learning and Poincaré density grid in the diagnosis of sinus node dysfunction caused by sinoatrial conduction block in dogs
Treatment Breakthroughs With Pimobendan
Pimobendan has reshaped the management of canine heart disease over the past decade. It works in two ways simultaneously: it strengthens the heart’s contraction and it dilates blood vessels, reducing the workload on an already struggling pump. What made this drug transformative was evidence that it helps not just dogs already in heart failure, but dogs in the preclinical stage, before symptoms appear.
The EPIC trial, a large randomized study of dogs with MMVD and heart enlargement but no clinical signs, found that starting pimobendan early extended the time before dogs developed heart failure by roughly 15 months compared to placebo. The median time to reaching heart failure or cardiac death was about 1,228 days with pimobendan versus 766 days with placebo, a hazard ratio of 0.64.20Journal of Veterinary Internal Medicine. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical Trial In Dobermans with preclinical DCM, the PROTECT study showed a similar benefit: dogs on pimobendan reached heart failure or sudden death at a median of 718 days compared to 441 days on placebo, an extension of about nine months.21Journal of Veterinary Internal Medicine. Efficacy of Pimobendan in the Prevention of Congestive Heart Failure or Sudden Death in Doberman Pinschers with Preclinical Dilated Cardiomyopathy (The PROTECT Study)
These findings changed clinical guidelines. Pimobendan is now recommended for dogs with MMVD or DCM once cardiac enlargement is confirmed on imaging, even if the dog still seems perfectly healthy. For owners, the takeaway is that detecting heart enlargement before symptoms develop, and starting treatment at that point, genuinely buys meaningful time. This is why veterinary cardiologists push so hard for regular screening in predisposed breeds.
Nutrition Beyond the Grain-Free Question
Diet matters for dogs with established heart disease in ways that go beyond ingredient controversies. Heart failure drives a catabolic state where the body breaks down its own muscle for energy, a process called cardiac cachexia. Dogs in heart failure often lose significant lean body mass even when they appear to be eating adequately. Research has shown that supplementing with fish oil, which is rich in omega-3 fatty acids, can lower inflammatory cytokine levels and improve the muscle wasting associated with heart failure.22Journal of Veterinary Internal Medicine. Cachexia and Sarcopenia: Emerging Syndromes of Importance in Dogs and Cats In one controlled trial, dogs receiving fish oil had lower concentrations of the inflammatory marker IL-1β and less cachexia than those on placebo. Reductions in IL-1β also predicted longer survival, suggesting that dialing down inflammation in heart-failure patients has real prognostic value.23PubMed. Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure
Sodium restriction, once considered a cornerstone of heart-failure management in dogs, has become more debated. Moderate sodium reduction is still widely practiced, but very aggressive salt restriction can backfire by activating hormonal pathways that worsen fluid retention. Most veterinary cardiologists now recommend a moderate approach: avoiding high-sodium treats and table scraps while not obsessing over every milligram. Ensuring adequate caloric intake is equally important, because a dog that stops eating loses muscle and condition rapidly.
Exercise for Dogs With Heart Disease
A common question owners face after a cardiac diagnosis is whether their dog can still exercise. The instinct to restrict all activity is understandable but not always correct. For stable dogs with compensated heart failure, complete inactivity may actually be counterproductive, contributing to further muscle loss and deconditioning. Current expert recommendations support light walks lasting 20 to 30 minutes, two to three times per week, for dogs whose heart failure is well managed.24PubMed Central. Exercise Testing and Physical Activity in Dogs: From Health to Heart Disease
The key distinction is between stable and unstable disease. A dog in active congestive heart failure, with fluid accumulation in the lungs or abdomen, needs rest and aggressive medical management. But once medications have stabilized the condition and fluid has cleared, gentle activity supports cardiovascular conditioning and preserves muscle mass. You should watch for warning signs during exercise: excessive panting, reluctance to continue, coughing, or collapse. These indicate the dog has hit its limit and should stop.
The Heart-Kidney Connection
Heart disease and kidney disease frequently coexist in dogs, and each condition makes the other worse. When the heart fails to pump adequately, blood flow to the kidneys drops, impairing their ability to filter waste and regulate fluid balance. Conversely, kidney dysfunction causes fluid retention and electrolyte imbalances that place additional strain on the heart. Veterinary specialists have formalized this interplay under the term cardiovascular-renal disorders, or CvRD. A consensus statement from an international group of veterinary cardiologists and nephrologists established definitions and management strategies for dogs and cats caught in this cycle, emphasizing that treating one organ system without monitoring the other can lead to inadvertent harm.
In practice, this means that dogs on heart-failure medications like diuretics need regular kidney-value blood work, because the same drugs that pull fluid off the lungs can also push the kidneys into trouble. Veterinarians managing a dog with both cardiac and renal disease often find themselves walking a narrow therapeutic line, balancing fluid removal against kidney perfusion. For owners, the lesson is that blood work should not stop once a cardiac diagnosis is made. Kidney function is part of the cardiac picture, and catching early changes lets your vet adjust medications before a crisis develops.
Heatstroke as a Cardiac Emergency
Heatstroke is not typically filed under “cardiology,” but its cardiovascular consequences can be catastrophic. When a dog’s core temperature exceeds about 41°C (roughly 106°F), the body’s cooling systems have failed. Blood pools in the large internal organs, triggering a shock state that damages the intestinal lining and unleashes a systemic inflammatory response. Despite aggressive cooling and intensive supportive care, the mortality rate in dogs with heatstroke sits around 50 percent.25PubMed Central. Pathophysiology of heatstroke in dogs – revisited Dogs with pre-existing cardiac disease are at even higher risk, because their hearts are already compromised and less able to handle the circulatory upheaval. Brachycephalic breeds, dogs with heart murmurs, and overweight dogs all deserve extra vigilance during hot weather. Prevention is far more effective than treatment: access to shade, fresh water, avoidance of midday exertion, and never leaving a dog in a parked vehicle are measures that save lives every summer.